D.C. Appeals Court OKs "Authorized Generics"

Law360, New York (June 7, 2005, 12:00 AM EDT) -- In a decision with broad implications for the pharmaceutical industry, a U.S. appeals court has ruled that brand-name drug companies have the right to sell unbranded versions of their own drugs even if they undercut sales of generic competitors.

In a decision reached on Friday of last week, the U.S. Court of Appeals for the District of Columbia said the law doesn't prohibit drug companies from launching "authorized generics."

The decision marked a setback for Israeli generic maker Teva Pharmaceutical Industries Ltd., which had sued the...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.